Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.70 |
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.41 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | VDR | P11473 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL886839 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL4305284 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL5880596 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL3364295 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL3235123 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL8710870 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL17836872 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL3334632 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL22159996 | 1.00 | USP2 (0.70) | USP2HTTLPAR5PLA2G2CGAA | |
| SCHEMBL1206580 | 0.98 | USP2 (0.67) | USP2HTTLPAR5PLA2G2CGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100240794-A1 | DENTAL RESIN COMPOSITION, METHOD OF MANUFACTURE, AND METHOD OF USE THEREOF | PENTRON CORPORATION | 2010-09-23 | — | — | US | claimed |
| EP-2230286-A1 | Dental resin composition, method of manufacture, and method uf use thereof | Pentron Clinical Technologies, LLC (US) | 2010-09-22 | — | — | EP | claimed |
| JP-2002541238-A | — | — | 2002-12-03 | — | — | JP | claimed |
| EP-1183228-A2 | ESTERS OF L-CARNITINE OR ALKANOYL L-CARNITINES | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 2002-03-06 | — | — | EP | claimed |
| WO-2000061543-A2 | ESTERS OF L-CARNITINE OR ALKANOYL L-CARNITINES | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2000-10-19 | — | — | WO | claimed |
| US-12031006-B2 | Use of polyolethers for producing porous plastic coatings | EVONIK OPERATIONS GMBH (DE) | 2024-07-09 | — | — | US | disclosed |
| EP-3675994-A1 | USE OF POLYOLETHERS FOR PRODUCING POROUS PLASTIC COATINGS | Evonik Operations GmbH (DE) | 2020-07-08 | — | — | EP | disclosed |
| US-20200207938-A1 | USE OF POLYOLETHERS FOR PRODUCING POROUS PLASTIC COATINGS | EVONIK OPERATIONS GMBH (DE) | 2020-07-02 | — | — | US | disclosed |
| WO-2002051395-A1 | TREATMENT OF NEURODEGENERATIVE DISEASES | CODON PHARMACEUTICALS, INC. (US) | 2002-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100240794-A1 | DENTAL RESIN COMPOSITION, METHOD OF MANUFACTURE, AND METHOD OF USE THEREOF | MMAB, ACMSD, COPE | USP2 1524/4885HTT 3158/4885LPAR5 4427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.